Vinay Prasad's appointment as head of the FDA's Center for Biologics Evaluation and Research (CBER) attracts attention due to his renowned critical views on premature medical interventions in U.S. healthcare. Known for questioning the reliance on drugs without substantial evidence of
Former President Donald Trump's administration implemented significant policy changes that impacted the healthcare sector, with notable effects on the medtech industry. During his tenure, Trump's regulatory adjustments, workforce restructuring, and tariff strategies led to transformations
In today's rapidly evolving healthcare landscape, the integration of artificial intelligence is transformative yet challenging to regulate. To shed light on this crucial subject, we have Faisal Zain, a seasoned expert in medical technology and innovation. With a keen focus on the intersection
The healthcare reforms under President Donald Trump’s second term have profoundly reshaped the healthcare landscape in the United States. As these reforms continue to unfold, they spark both controversy and innovation, presenting opportunities and challenges that demand careful analysis for s
In a bold move to redefine medication accessibility, Petros Pharmaceuticals has announced a strategic pivot toward smart healthcare technology. This transformative shift is focused on expediting the transition of prescription medications to over-the-counter (OTC) availability. By leveraging
Faisal Zain, a renowned expert in healthcare and medical technology, joins us today to provide insights into the hospital expansion endeavors in North Carolina. With a focus on diagnostic and treatment device innovation, Faisal sheds light on the implications of rising hospital demands, the
